New Product Launch - SAN HQ GMP
Tromsø, Norway, January 30th, 2024 – ArcticZymes Technologies ASA (OSE:AZT) announces the launch of Salt Active Nuclease High Quality GMP Grade (SAN HQ GMP).
ArcticZymes Technologies Changes to the Board of Directors
Tromsø, Norway, May 13th, 2024—ArcticZymes Technologies (OSE: AZT) announces Nominations for new Board members and the resignations of the Chairman and a Board member.
Presentation of Q1 2024 Results
Tromsø, Norway, May 8th, 2024 – ArcticZymes Technologies (OSE: AZT) reported sales of NOK 30.0 million and an EBITDA of NOK 2.3 million for the first quarter of 2024.
Joint Research with Austrian Centre of Industrial Biotechnology
Tromsø, Norway, April 9, 2024 - ArcticZymes Technologies ASA (OSE: AZT) and the Austrian Centre of Industrial Biotechnology (acib) enter a joint research project to uncover the benefits of salt active nucleases in the purification of bionanoparticles (BNP’s).
Research Paper on ArcticZymes R2D Ligase Published in the Biotechnology Journal
Tromsø, Norway, March 27, 2024 - ArcticZymes Technologies ASA (OSE: AZT) Research Paper on ArcticZymes R2D Ligase™ is published in the Biotechnology Journal